Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Women's issues in venous thromboembolism.

Deborah L Ornstein1, Mary Cushman

  • 1Department of Medicine, University of Vermont College of Medicine/Fletcher Allen Health Care, University Health Center Campus, 1 South Prospect Street, Burlington, VT 05401, USA. deborah.ornstein@vtmednet.org

Current Hematology Reports
|September 3, 2004
PubMed
Summary

Venous thromboembolism (VTE) affects women uniquely due to factors like hormonal contraceptives, pregnancy, and hormone replacement therapy. Breast cancer treatments also impact women

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic coagulation is activated in patients with meningioma and glioblastoma.

Journal of neuro-oncology·2021
Same author

Plasma cell variant of Castleman lymphadenopathy presenting as an adrenal mass.

Urology case reports·2021
Same author

Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2019
Same author

Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.

International journal of cardiology·2019
Same author

Is Family Caregiving Associated With Inflammation or Compromised Immunity? A Meta-Analysis.

The Gerontologist·2019
Same author

Association of secondhand tobacco smoke exposure during childhood on adult cardiovascular disease risk among never-smokers.

Annals of epidemiology·2019

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Oncology

Background:

  • Venous thromboembolism (VTE) occurs in men and women at similar rates.
  • Unique risk factors for VTE in women include hormonal contraceptives, pregnancy, and hormone replacement therapy.
  • Breast cancer therapies can influence a woman's thrombotic risk.

Purpose of the Study:

  • To review venous thromboembolism (VTE) specifically in women.
  • To highlight unique aspects of VTE care for female patients.
  • To illustrate clinical considerations using case examples.

Main Methods:

  • Review of clinical practice cases involving women with VTE.
  • Analysis of VTE risk factors specific to female physiology and treatments.
  • Literature review on VTE in women.

Related Experiment Videos

Main Results:

  • Hormonal contraceptives and pregnancy elevate VTE risk in childbearing-aged women.
  • Hormone replacement therapy increases VTE risk in postmenopausal women.
  • Certain breast cancer treatments are associated with higher VTE incidence.

Conclusions:

  • VTE management in women requires consideration of specific physiological and therapeutic factors.
  • Understanding unique risk factors is crucial for preventing VTE in women.
  • Clinical practice highlights the importance of individualized VTE risk assessment for women.